GPX4 has been reported to be overexpressed in cancer tissues compared to normal tissues and to be associated with low levels of DNA methylation and enrichment of H3K4me3 and H3K27ac marks at its promoter, suggesting that epigenetic regulation may be involved in its aberrant overexpression22. The gene discussed is GPX4; the disease is cancer.